共 50 条
- [22] Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile ATHEROSCLEROSIS PLUS, 2021, 43 : 7 - 9
- [26] Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07): : 743 - 753